Delisting risk
Purple Biotech (ADR) (PPBT)
Develops CAPTN-3 tri-specific cancer antibodies and other oncology drug candidates.
$1.86
Pre-market−0.12 (−6.02%)
At close$1.98(+18.98%)
Something off on this page? Send us feedback.
Next report
Nov 13, 2026
estimated · in 71 days
EPS estimate
−$2.88
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.26−$0.17−$0.40−$0.29−$19.85−$0.09$1.07Pending
Estimate−$0.22—−$0.21−$0.26−$3.40−$3.80−$0.98−$2.88
Surprise−18.2%—−90.5%−11.5%−483.8%+97.6%+209.2%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported———————Pending
Estimate————————
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$2.88 | — | — |
| Aug 2026 | −$0.98 | $1.07 | +209.2% |
| May 2026 | −$3.80 | −$0.09 | +97.6% |
| Mar 2026 | −$3.40 | −$19.85 | −483.8% |
| Nov 2025 | −$0.26 | −$0.29 | −11.5% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Sep 2021 | |||
| Aug 2021 | |||
| Mar 2021 | |||
| Mar 2021 | |||
| Sep 2020 | |||
| Aug 2020 | |||
| Mar 2020 | |||
| Feb 2020 | |||
| Sep 2019 | |||
| Aug 2019 | |||
| Mar 2019 | |||
| Feb 2019 | |||
| Sep 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Dec 2017 | |||
| Sep 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Dec 2016 | |||
| Sep 2016 | |||
| Aug 2016 | |||
| Mar 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Jun 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 13, 2026 | −$2.88 | — | — | — | — | — | — |
| Aug 7, 2026 | −$0.98 | $1.07 | +209.2% | — | — | — | +1.4% |
| May 15, 2026 | −$3.80 | −$0.09 | +97.6% | — | — | — | −4.1% |
| Mar 13, 2026 | −$3.40 | −$19.85 | −483.8% | — | — | — | −0.2% |
| Nov 14, 2025 | −$0.26 | −$0.29 | −11.5% | — | — | — | +0.3% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||||||
| Aug 6, 2025 | |||||||
| May 21, 2025 | |||||||
| Mar 10, 2025 | |||||||
| Nov 15, 2024 | |||||||
| Aug 16, 2024 | |||||||
| May 21, 2024 | |||||||
| Mar 5, 2024 | |||||||
| Nov 21, 2023 | |||||||
| Aug 22, 2023 | |||||||
| May 16, 2023 | |||||||
| Feb 8, 2023 | |||||||
| Nov 8, 2022 | |||||||
| Aug 4, 2022 | |||||||
| May 12, 2022 | |||||||
| Feb 9, 2022 | |||||||
| Sep 30, 2021 | |||||||
| Aug 5, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Mar 2, 2021 | |||||||
| Sep 30, 2020 | |||||||
| Aug 11, 2020 | |||||||
| Mar 31, 2020 | |||||||
| Feb 11, 2020 | |||||||
| Sep 30, 2019 | |||||||
| Aug 8, 2019 | |||||||
| Mar 31, 2019 | |||||||
| Feb 7, 2019 | |||||||
| Sep 30, 2018 | |||||||
| Aug 29, 2018 | |||||||
| May 5, 2018 | |||||||
| Dec 31, 2017 | |||||||
| Sep 30, 2017 | |||||||
| Aug 16, 2017 | |||||||
| May 1, 2017 | |||||||
| Dec 31, 2016 | |||||||
| Sep 30, 2016 | |||||||
| Aug 17, 2016 | |||||||
| Mar 31, 2016 | |||||||
| Mar 18, 2016 | |||||||
| Nov 25, 2015 | |||||||
| Jun 30, 2015 | |||||||